JP2002525081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002525081A5 JP2002525081A5 JP2000571058A JP2000571058A JP2002525081A5 JP 2002525081 A5 JP2002525081 A5 JP 2002525081A5 JP 2000571058 A JP2000571058 A JP 2000571058A JP 2000571058 A JP2000571058 A JP 2000571058A JP 2002525081 A5 JP2002525081 A5 JP 2002525081A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- sequence
- seq
- antibody
- polypeptide encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000040430 polynucleotide Human genes 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9815898P | 1998-08-27 | 1998-08-27 | |
| US13268499P | 1999-05-05 | 1999-05-05 | |
| US60/098,158 | 1999-05-05 | ||
| US60/132,684 | 1999-05-05 | ||
| PCT/US1999/020394 WO2000012525A1 (en) | 1998-08-27 | 1999-08-27 | Sequences characteristic of hypoxia-regulated gene transcription |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002525081A JP2002525081A (ja) | 2002-08-13 |
| JP2002525081A5 true JP2002525081A5 (enExample) | 2006-10-12 |
Family
ID=26794273
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567249A Pending JP2002523072A (ja) | 1998-08-27 | 1999-08-27 | 低酸素症調節遺伝子 |
| JP2000571058A Pending JP2002525081A (ja) | 1998-08-27 | 1999-08-27 | 低酸素により調節される遺伝子転写に特徴的な配列 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567249A Pending JP2002523072A (ja) | 1998-08-27 | 1999-08-27 | 低酸素症調節遺伝子 |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP1115733A4 (enExample) |
| JP (2) | JP2002523072A (enExample) |
| AU (1) | AU5810999A (enExample) |
| CA (2) | CA2341518A1 (enExample) |
| IL (2) | IL141666A0 (enExample) |
| WO (2) | WO2000012139A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4175662B2 (ja) | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ．ヴイ． | 電気的筋肉制御装置 |
| US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
| US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
| EP1002862A1 (en) * | 1998-11-12 | 2000-05-24 | Nitsch, Roger M., Prof. Dr. | Methods of diagnosing or treating neurological diseases |
| US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
| JP2004526426A (ja) * | 2000-11-28 | 2004-09-02 | ワイス | 前立腺癌の診断および治療に有用なｋｉａａ核酸およびポリペプチドの発現分析 |
| DE60237406D1 (de) * | 2001-05-31 | 2010-09-30 | Chiba Prefecture | Aus einem Neuroblastom isolierte Nukleinsäuren |
| AU2002324451A1 (en) | 2001-06-21 | 2003-01-08 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| JP2006515747A (ja) * | 2002-11-01 | 2006-06-08 | ジェネンテック・インコーポレーテッド | 免疫関連疾患の治療のための組成物と方法 |
| US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
| US20080249038A1 (en) * | 2003-10-07 | 2008-10-09 | Quark Biotech, Inc. | Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof |
| US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
| WO2006119467A2 (en) | 2005-05-04 | 2006-11-09 | Impulse Dynamics Nv | Protein activity modification |
| EP1827571B1 (en) | 2004-12-09 | 2016-09-07 | Impulse Dynamics NV | Protein activity modification |
| US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
| JP2011206049A (ja) * | 2010-03-08 | 2011-10-20 | Sumio Sugano | 壊死マーカー及びその用途 |
| JP2013220090A (ja) * | 2012-04-19 | 2013-10-28 | Tohoku Univ | 眼疾患治療に使用する薬剤スクリーニング方法 |
| CN110177544A (zh) | 2016-11-29 | 2019-08-27 | 普尔泰克健康有限公司 | 用于递送治疗剂的外泌体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2240492A (en) | 1991-06-20 | 1993-01-25 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Sequences characteristic of human gene transcription product |
| US5731294A (en) * | 1993-07-27 | 1998-03-24 | Hybridon, Inc. | Inhibition of neovasularization using VEGF-specific oligonucleotides |
| US5882914A (en) * | 1995-06-06 | 1999-03-16 | The Johns Hopkins University School Of Medicine | Nucleic acids encoding the hypoxia inducible factor-1 |
| WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| EP1002862A1 (en) * | 1998-11-12 | 2000-05-24 | Nitsch, Roger M., Prof. Dr. | Methods of diagnosing or treating neurological diseases |
-
1999
- 1999-08-27 JP JP2000567249A patent/JP2002523072A/ja active Pending
- 1999-08-27 WO PCT/US1999/020393 patent/WO2000012139A1/en not_active Ceased
- 1999-08-27 EP EP99945523A patent/EP1115733A4/en not_active Withdrawn
- 1999-08-27 EP EP99945522A patent/EP1107797A4/en not_active Withdrawn
- 1999-08-27 CA CA002341518A patent/CA2341518A1/en not_active Abandoned
- 1999-08-27 IL IL14166699A patent/IL141666A0/xx unknown
- 1999-08-27 JP JP2000571058A patent/JP2002525081A/ja active Pending
- 1999-08-27 IL IL14166099A patent/IL141660A0/xx unknown
- 1999-08-27 AU AU58109/99A patent/AU5810999A/en not_active Abandoned
- 1999-08-27 CA CA002341705A patent/CA2341705A1/en not_active Abandoned
- 1999-08-27 WO PCT/US1999/020394 patent/WO2000012525A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002525081A5 (enExample) | ||
| JP2004511430A5 (enExample) | ||
| JP2003522514A5 (enExample) | ||
| JP2002527052A5 (enExample) | ||
| JP2002541233A5 (enExample) | ||
| JP2008538183A5 (enExample) | ||
| JP2004525922A5 (enExample) | ||
| WO2002043661A3 (en) | Recombinant anti-cd30 antibodies and uses thereof | |
| JP2008525033A5 (enExample) | ||
| JP2002508183A5 (enExample) | ||
| JP2001514858A5 (enExample) | ||
| RU2006144093A (ru) | Полипептиды нетипируемой haemophilus influenzae | |
| JP2002508970A5 (enExample) | ||
| JP2002505841A5 (enExample) | ||
| JP2002500886A5 (enExample) | ||
| JP2004518624A5 (enExample) | ||
| JP2004504032A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| CA2370814A1 (en) | Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit | |
| NZ607886A (en) | Nogo receptor binding protein | |
| JP2003525623A5 (enExample) | ||
| JP2003534287A5 (enExample) | ||
| JP2002532079A5 (enExample) | ||
| JP2002522512A5 (enExample) | ||
| EP1960426A4 (en) | NEW NEUROTROPHIC FACTOR AND USES THEREOF |